{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:59Z","timestamp":1786118939326,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1097\/gme.0b013e31817e5cce","type":"journal-article","created":{"date-parts":[[2008,7,2]],"date-time":"2008-07-02T03:06:34Z","timestamp":1214967994000},"page":"804-809","source":"Crossref","is-referenced-by-count":4,"title":["Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk"],"prefix":"10.1097","volume":"15","author":[{"given":"Nananda F.","family":"Col","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowan T.","family":"Chlebowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl 1","key":"R1-7-20210227","first-page":"168","article-title":"Persistent hot flashes in older postmenopausal women Abstract.","volume":"22","author":"Huang","year":"2007","journal-title":"J Gen Intern Med"},{"key":"R2-7-20210227","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.GME.0000155200.80687.BE","article-title":"Hot flushes during the menopause transition: a longitudinal study in Australian-born women.","volume":"12","author":"Guthrie","year":"2005","journal-title":"Menopause"},{"issue":"Suppl 12B","key":"R3-7-20210227","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2005.09.031","article-title":"Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives.","volume":"118","author":"Woods","year":"2005","journal-title":"Am J Med"},{"key":"R5-7-20210227","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0378-5122(92)90003-M","article-title":"The normal menopause transition.","volume":"14","author":"McKinlay","year":"1992","journal-title":"Maturitas"},{"key":"R6-7-20210227","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2105\/AJPH.92.11.1832","article-title":"Ethnic differences in us of complementary and alternative medicine at midlife: longitudinal results from SWAN participants.","volume":"92","author":"Bair","year":"2002","journal-title":"Am J Public Health"},{"key":"R7-7-20210227","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/jnci\/djm223","article-title":"Projecting individualized absolute invasive breast cancer risk in African American women.","volume":"99","author":"Gail","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R8-7-20210227","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5","article-title":"Autosomal dominant inheritance of early-onset breast cancer: implications for risk prediction.","volume":"73","author":"Claus","year":"1994","journal-title":"Cancer"},{"key":"R9-7-20210227","first-page":"333","article-title":"Comparisons of two breast cancer risk estimates in women with a family history of breast cancer.","volume":"10","author":"McTiernan","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R10-7-20210227","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/jnci\/djm224","article-title":"Predicting risk of breast cancer in postmenopausal women by hormone receptor status.","volume":"99","author":"Chlebowski","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R11-7-20210227","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/jnci\/djm223","article-title":"Projecting individualized absolute invasive breast cancer risk in African American women.","volume":"99","author":"Gail","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R12-7-20210227","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","article-title":"Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.","volume":"62","author":"Parmigiani","year":"1998","journal-title":"Am J Hum Genet"},{"key":"R13-7-20210227","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A breast cancer prediction model incorporating familial and personal risk factors.","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat Med"},{"key":"R14-7-20210227","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R15-7-20210227","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"key":"R16-7-20210227","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1158\/1055-9965.EPI-04-0758","article-title":"Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups.","volume":"15","author":"Kaplan","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R17-7-20210227","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jnci\/djm032","article-title":"Researchers wonder why high-risk women are not taking chemoprevention drugs News.","volume":"99","author":"Savage","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R18-7-20210227","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/0162243904264960","article-title":"Constructing \"high risk women\": the development and standardization of a breast cancer risk assessment tool.","volume":"29","author":"Fosket","year":"2004","journal-title":"Sci Technol Hum Values"},{"key":"R19-7-20210227","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1001\/archinte.166.20.2260","article-title":"Prescription of tamoxifen for breast cancer prevention by primary care physicians.","volume":"166","author":"Armstrong","year":"2006","journal-title":"Arch Intern Med"},{"key":"R20-7-20210227","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jnci\/dji128","article-title":"Cancer risk prediction models: a workshop on development, evaluation, and application.","volume":"97","author":"Freedman","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R21-7-20210227","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1748-5908-1-16","article-title":"Barriers and facilitators to implementing shared decision-making in clinical practice: a systematic review of health professionals' perceptions.","volume":"1","author":"Gravel","year":"2006","journal-title":"Implement Sci"},{"key":"R22-7-20210227","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1748-5908-3-2","article-title":"Translating shared decision-making into health care clinical practices: proof of concepts.","volume":"3","author":"Legare","year":"2008","journal-title":"Implement Sci"},{"key":"R23-7-20210227","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/0272989X07307270","article-title":"Communicating the uncertainty of harms and benefits of medical interventions.","volume":"27","author":"Politi","year":"2007","journal-title":"Med Decis Making"},{"key":"R24-7-20210227","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/jnci\/86.8.600","article-title":"Validation of the Gail et al. model for predicting individual breast cancer risk.","volume":"86","author":"Spiegelman","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"R25-7-20210227","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/jnci\/93.5.358","article-title":"Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.","volume":"93","author":"Rockhill","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"R26-7-20210227","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1006478317173","article-title":"Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial.","volume":"65","author":"Cauley","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"R27-7-20210227","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/gme.0b013e318178863e","article-title":"Chemoprevention in postmenopausal women.","volume":"15","author":"Rastogi","year":"2008","journal-title":"Menopause"},{"key":"R28-7-20210227","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"R29-7-20210227","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.maturitas.2006.05.004","article-title":"Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.","volume":"55","author":"Anderson","year":"2006","journal-title":"Maturitas"},{"key":"R30-7-20210227","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"key":"R31-7-20210227","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1001\/archinte.164.15.1634","article-title":"Short-term menopausal hormone therapy for symptom relief: an updated decision model.","volume":"164","author":"Col","year":"2004","journal-title":"Arch Intern Med"},{"key":"R32-7-20210227","first-page":"1049","article-title":"Effects of conjugated equine estrogens on breast cancer and mammography in postmenopausal women with hysterectomy: the Women's Health Initiative randomized trial.","volume":"242","author":"Stefanick","year":"2006","journal-title":"JAMA"},{"key":"R33-7-20210227","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archinternmed.2007.123","article-title":"Estrogen plus progestin and breast cancer detection with mammography and breast biopsy.","volume":"168","author":"Chlebowski","year":"2008","journal-title":"Arch Intern Med"},{"key":"R34-7-20210227","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"key":"R35-7-20210227","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(98)85012-5","article-title":"Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital Tamoxifen Randomized Chemoprevention Trial.","volume":"352","author":"Powles","year":"1998","journal-title":"Lancet"},{"key":"R36-7-20210227","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1200\/JCO.2001.19.4.980","article-title":"Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer.","volume":"19","author":"Ravdin","year":"2001","journal-title":"J Clin Oncol"},{"key":"R38-7-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/027298902236942","article-title":"The survival impact of tamoxifen use for breast cancer risk reduction: Projection from a patient-specific marker model.","volume":"22","author":"Col","year":"2002","journal-title":"Med Decis Making"},{"key":"R39-7-20210227","first-page":"E81","article-title":"Impact of an individualized web-based decision support on decisional conflict abstract.","volume":"27","author":"Col","year":"2007","journal-title":"Med Decis Making"},{"key":"R40-7-20210227","first-page":"E27","article-title":"Impact of individualized web-based decision support on medication use abstract.","volume":"27","author":"Col","year":"2007","journal-title":"Med Decis Making"},{"key":"R41-7-20210227","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.maturitas.2007.02.020","article-title":"Using Internet technologies to improve and simplify counseling about menopause.","volume":"57","author":"Col","year":"2007","journal-title":"Maturitas"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/gme.0b013e31817e5cce","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:11:51Z","timestamp":1786036311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042192-200815041-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e31817e5cce","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}